CONGRESS ABSTRACT

Background Myocarditis and pericarditis are inflammatory cardiac diseases with heterogeneous clinical presentations, ranging from mild to life-threatening conditions, and occur more frequently in young adult males. Purpose and Methods This observational study included adult patients with cardiac magnetic resonance (CMR)-confirmed myocarditis admitted to a high-volume cardiology center between March…

Background Climate change and environmental degradation are increasingly recognized as major determinants of cardiovascular health. Heart failure (HF), characterized by limited hemodynamic and autonomic reserve, appears particularly sensitive to ambient environmental stressors, yet remains underrepresented in climate–cardiology research. Objective To synthesize current epidemiological and mechanistic evidence linking climate-related environmental…

Background: Transthyretin Amyloid Cardiomyopathy (ATTR-CM) is a rare disease associated with a substantial impairment in patients’ psychophysical well-being and quality of life. Purpose: to describe the difference in anxiety, depression, symptom percepition, and fatigue between five years follow-up patients with ATTR-CM treated with tafamidis and those not receiving ATTR-CM…

Background: Left bundle branch block (LBBB) is a major determinant of electrical and mechanical dyssynchrony in heart failure with reduced ejection fraction (HFrEF), contributing to adverse ventricular remodeling and poor prognosis. Although cardiac resynchronization therapy improves outcomes, a substantial proportion of patients show limited response. Left bundle branch pacing…

Arrhythmias represent one of the most frequent and clinically significant challenges in Cardio-Thoracic-Vascular Intensive Care Units (CTV-ICUs), where timely recognition and appropriate management of rhythm disturbances are crucial for patient safety and clinical outcomes. Despite technological advances, recent studies have shown that more than 80% of arrhythmia alarms in…

Background: The Cardio-Kidney-Metabolic (CKM) syndrome represents a clinical continuum where metabolic disorders, chronic kidney disease (CKD), and heart failure (HF) mutually exacerbate cardiovascular risk. Despite international guidelines recommending SGLT2 inhibitors (SGLT2i) as a cornerstone of treatment across the entire ejection fraction spectrum, a significant therapeutic gap persists in clinical…